Therapeutic Confirmatory (Phase III)

3,259 trials 1,319 recruiting

Filter these 3,259 trials by condition, country, sponsor and more.

Open in Search →

The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its influence on endoth… Ended

2024-511894-32-00 Ischemia of the lower limbs in the course of obstructiv 2021-08-19
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic… Ended

2023-506752-24-00 Locally recurrent inoperable or metastatic HR+/HER2- br 2021-08-05
A Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel versus Bortezomib, Len… Ended

2023-505850-16-00 Multiple Myeloma 2021-08-05
PEITHO-3 - A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism: a randomized controll… Ended

2024-511321-54-00 intermediate-high-risk acute pulmonary embolism 2021-08-04
Study of Subcutaneous Pembrolizumab versus Intravenous Pembrolizumab, Given with Chemotherapy, to Treat Metastatic Squamous or Non Squamous … Ended

2023-508308-40-00 Metastatic (stage IV) squamous or nonsquamous non-small 2021-07-30
Improvement of Live Babies Rates After ICSI, Using cpFT Ended

2024-514350-78-00 Infertility 2021-07-29
A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation (ATLAS) Ended

2023-505641-12-00 Amyotrophic Lateral Sclerosis (ALS) associated with SOD 2021-07-27
NADINA Ended

2024-513519-28-00 Stage III melanoma 2021-07-23
Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab Ended

2024-516543-26-00 Type 1 Diabetes Mellitus 2021-07-23
AHEAD 3-45 Study: A Clinical Study to Investigate the Effects of BAN2401 in Subjects With Preclinical Alzheimer’s Disease Ended

2024-510888-39-00 Early Preclinical Alzheimer’s Disease and Intermediate 2021-07-21
DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801). A randomised phase 3 dou… Ended

2024-514565-18-00 Localised Very High-Risk Cancer of the Prostate 2021-07-20
Hydrocorticose and vasopressin in post-resuscitation syndrome Ended

2024-516373-77-00 Adult cardiac arrest patients with sustained ROSC and h 2021-07-18
Extension Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Who Previously Participated in a Study With Nusinersen … Ended

2023-505637-27-00 Spinal Muscular Atrophy 2021-07-12
A clinical study to compare Toripalimab (JS001) combined with Lenvatinib versus placebo combined with Lenvatinib as the 1st-line therapy for… Ended

2024-514207-34-00 Advanced hepatocellular carcinoma (HCC) 2021-07-08
A Phase 3 Open Label, Randomized Study of LOXO 305 versus Investigator's Choice of Idelalisib plus Rituximab or Bendamustine plus Rituximab … Ended

2023-507697-40-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2021-07-05
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Acute lymphoblastic leukemia 2021-07-01
A Study Evaluating the Efficacy and Safety of Crovalimab in Adult and Adolescent Patients with atypical Hemolytic Uremic Syndrome (aHUS) Ended

2023-505089-27-00 Atypical Hemolytic Uremic Syndrome (aHUS) 2021-07-01
Efficacy and Safety Comparison of Niraparib to Placebo in Participants with HER2 Negative BRCAmut or Triple-Negative Breast Cancer with Mole… Ended

2023-504454-35-00 Neoplasms, Breast 2021-06-22
Optimizing MATRix, a combination of Methotrexate, Ara-C, Thiotepa and Rituximab given as an induction therapy, de-escalated in duration and … Ended

2024-514473-21-00 Primary diffuse large B-cell lymphoma (DLBCL) of the ce 2021-06-21
PSMAfore: A phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of androgen receptor-directed therap… Ended

2023-507772-50-00 PSMA-positive metastatic castration-resistant prostate 2021-06-16
Phase Ib/III Study of Capivasertib + CDK4/6 Inhibitors + Fulvestrant as Treatment for Advanced/Metastatic HR+/HER2-Breast Cancer (CAPItello-… Ended

2023-504997-39-00 Hormone Receptor-Positive and Human Epidermal Growth Fa 2021-06-14
Long-term safety of apraglutide in short bowel syndrome Ended

2023-510389-28-00 short bowel syndrome 2021-06-14
Protocol Title: Phase 3, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of PF-07055480 (Recombinant AAV2/6 Human Factor VI… Ended

2024-512075-12-00 hemophilia A 2021-06-14
A Study of the Efficacy and Safety of Galinpepimut-S (GPS) for the Treatment of Acute Myeloid Leukemia Compared to Investigator's Choice of … Ended

2024-516405-23-00 Acute myeloid leukemia (AML) in second or later complet 2021-06-08